Management of Strep Pharyngitis

Current Guideline Recommendations

The Infectious Diseases Society of America (IDSA) explicitly recommends against using corticosteroids as adjunctive therapy for Group A Streptococcal (GAS) pharyngitis (weak recommendation, moderate quality evidence) 1, 3
For pain management in strep pharyngitis, guidelines recommend using Acetaminophen or NSAIDs (such as ibuprofen) as first-line adjunctive therapy alongside appropriate antibiotics (strong recommendation, high quality evidence) 1, 3, 4
The American Academy of Family Physicians recommends avoiding aspirin in children due to risk of Reye syndrome (strong recommendation, moderate quality evidence) 3
Topical therapies like lozenges, sprays, or warm salt water gargles may provide temporary symptomatic relief 3

Studies show corticosteroids can decrease duration and severity of symptoms in GAS pharyngitis in both adults and children 3
The actual decrease in pain duration with corticosteroids is minimal (approximately 5 hours) 3

Given the self-limited nature of GAS pharyngitis, the potential adverse effects of systemic corticosteroids outweigh the modest benefits in pain reduction 3
Appropriate antibiotic therapy (penicillin or amoxicillin as first-line) is effective in reducing symptom duration 4

NSAIDs such as ibuprofen have demonstrated significant benefits in reducing fever and pain in both children and adults with pharyngitis 3
Acetaminophen provides significant pain relief compared to placebo, though possibly less effective than ibuprofen 3
Topical agents containing local anesthetics (ambroxol, lidocaine, benzocaine) may provide temporary symptomatic relief 3

The primary focus in strep pharyngitis should be appropriate antibiotic therapy to prevent complications (rheumatic fever, peritonsillar abscess) and reduce symptom duration 3, 4
Pain management should be considered adjunctive to appropriate antibiotic therapy 4